Mercator MedSystems announced last week that it finished enrollment for a six-month trial of its Bullfrog micro-infusion device in patients with below-the-knee critical limb ischemia. The Emeryville, Calif.-based company’s 120-patient trial was designed to evaluate if Mercator’s Bullfrog device can improve blood flow and reduce the occurrence of restenosis following atherectomy-based revascularization. Mercator’s micro-infusion device delivers […]
Mercator MedSystems said today that the 1st patient was enrolled in its Tango clinical trial. The trial is evaluating Mercator’s Bullfrog micro-infusion device for the adventitial delivery of temsirolimus below the knee in patients with critical limb ischemia. The Tango trial is the 4th ongoing clinical trial using the Bullfrog device in below the knee applications […]
Mercator MedSystems touted data today from its Dance clinical trial evaluating the company’s Bullfrog micro-infusion device as a delivery system for a generic anti-inflammatory steroid, dexamethasome. Mercator’s results were presented at the International Symposium on Endovascular Therapy and Leipzig Interventional Course. The steroid was delivered to tissues around femoropopliteal arteries after patients underwent endovascular intervention […]
Medtronic (NYSE:MDT) this week released data from 2 clinical studies evaluating its In.Pact Admiral drug-coated balloon for treating claudication and restenosis, touting sustained durability at 3-years. Results were presented at the Vascular Interventional Advances 2016 conference in Las Vegas this week. Those of you who want strength without size, lean muscles, or if you’re cutting, http://topsteroidsforsale.com is relatively safe […]
Mercator MedSystems said today it enrolled the 1st patient in the Limbo-ATx trial of the company’s Bullfrog micro-infusion device. The trial is slated to enroll 120 patients and aims to explore the benefit of localized drug delivery using the company’s device in maintaining vascular health when used alongside atherectomy procedures, the company said. “This is a very […]
Mercator MedSystems said yesterday it enrolled the 1st patient in its Limbo-PTA clinical trial aiming to examine the use of the company’s Bullfrog micro-infusion device delivering anti-inflammatory steroids along with angioplasty to treat patients with below the knee critical limb ischemia. The Emeryville, Calif.-based company said that the purpose of adding an anti-inflammatory drug, delivered by […]
April 25, 2014 by Brian Johnson
Patrick Sabaria, a medical device pioneer who helped establish the intraocular lens and the coronary stent in Europe, passed away unexpectedly last month. Sabaria was 61.
Louis Krami, CEO of Idaho’s Bingham Memorial Hospital, admitted to 2nd degree stalking charges after he ordered hospital IT staff to record the phone calls of former Bingham doctor Robert Rosin and his staff.
In the culmination of the 18-month investigation, Krami faces 30 days in behind bars, a $1,000 fine and 100 hours of community service. Hospital IT employees Chris Behunin, Tyler Lassen and IT director Jack York were also implicated in the illegal wiretap activity.
Privately held Mercator MedSystems plans to launch sales of its Bullfrog and Cricket micro-infusion systems with the new $6.5 million in funding the California company raised in a Series B round.
Mercator will initiate sales in Europe, the U.S. and Australia, and will also use the funds to support clinical studies of its peripheral artery disease product platform.